Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Daewoong Pharmaceutical Co. Ltd.
DescriptionAmyloid beta aggregation inhibitor
Molecular Target Amyloid
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today